APO RESEARCH · REPORT
Artemisinin
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
Product & engineering
Understand the product.
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
Selected research
Industry Research
Artemisinin Industry Research Report 2026
Market perspective
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.
Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.
Read the full market overview
In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 80%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.
Report Scope
This report quantifies the global Artemisinin market in revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Artemisinin.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Artemisinin Market by Company
Sanofi
KPC Pharmaceuticals
Kerui nanhai
Guangxi xiancaotang
Guilin Pharmaceutical
Natural Bio-engineering
BIONEXX
CAT KHANH
BEEPZ
Novanat Bioresource
Artemisinin Segment by Type
Extraction From Artemisia Annua
Semisynthetic Artemisinin
Artemisinin Segment by Application
Antimalarial Injections
Antimalarial Tablets
Artemisinin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artemisinin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Artemisinin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Artemisinin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Artemisinin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Extraction From Artemisia Annua
- Semisynthetic Artemisinin
Applications
- Antimalarial Injections
- Antimalarial Tablets
Companies covered
- Sanofi
- KPC Pharmaceuticals
- Kerui nanhai
- Guangxi xiancaotang
- Guilin Pharmaceutical
- Natural Bio-engineering
- BIONEXX
- CAT KHANH
- BEEPZ
- Novanat Bioresource
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Artemisinin by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Extraction From Artemisia Annua
- 2.2.3 Semisynthetic Artemisinin
- 2.3 Artemisinin by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Antimalarial Injections
- 2.3.3 Antimalarial Tablets
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Artemisinin Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Artemisinin Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Artemisinin Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Artemisinin Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Artemisinin Production by Manufacturers (2021-2026)
- 3.2 Global Artemisinin Production Value by Manufacturers (2021-2026)
- 3.3 Global Artemisinin Average Price by Manufacturers (2021-2026)
- 3.4 Global Artemisinin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Artemisinin Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Artemisinin Manufacturers, Product Type & Application
- 3.7 Global Artemisinin Manufacturers Established Date
- 3.8 Global Artemisinin Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Artemisinin Company Information
- 4.1.2 Sanofi Artemisinin Business Overview
- 4.1.3 Sanofi Artemisinin Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Sanofi Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 KPC Pharmaceuticals
- 4.2.1 KPC Pharmaceuticals Artemisinin Company Information
- 4.2.2 KPC Pharmaceuticals Artemisinin Business Overview
- 4.2.3 KPC Pharmaceuticals Artemisinin Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 KPC Pharmaceuticals Product Portfolio
- 4.2.5 KPC Pharmaceuticals Recent Developments
- 4.3 Kerui nanhai
- 4.3.1 Kerui nanhai Artemisinin Company Information
- 4.3.2 Kerui nanhai Artemisinin Business Overview
- 4.3.3 Kerui nanhai Artemisinin Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Kerui nanhai Product Portfolio
- 4.3.5 Kerui nanhai Recent Developments
- 4.4 Guangxi xiancaotang
- 4.4.1 Guangxi xiancaotang Artemisinin Company Information
- 4.4.2 Guangxi xiancaotang Artemisinin Business Overview
- 4.4.3 Guangxi xiancaotang Artemisinin Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Guangxi xiancaotang Product Portfolio
- 4.4.5 Guangxi xiancaotang Recent Developments
- 4.5 Guilin Pharmaceutical
- 4.5.1 Guilin Pharmaceutical Artemisinin Company Information
- 4.5.2 Guilin Pharmaceutical Artemisinin Business Overview
- 4.5.3 Guilin Pharmaceutical Artemisinin Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Guilin Pharmaceutical Product Portfolio
- 4.5.5 Guilin Pharmaceutical Recent Developments
- 4.6 Natural Bio-engineering
- 4.6.1 Natural Bio-engineering Artemisinin Company Information
- 4.6.2 Natural Bio-engineering Artemisinin Business Overview
- 4.6.3 Natural Bio-engineering Artemisinin Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Natural Bio-engineering Product Portfolio
- 4.6.5 Natural Bio-engineering Recent Developments
- 4.7 BIONEXX
- 4.7.1 BIONEXX Artemisinin Company Information
- 4.7.2 BIONEXX Artemisinin Business Overview
- 4.7.3 BIONEXX Artemisinin Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 BIONEXX Product Portfolio
- 4.7.5 BIONEXX Recent Developments
- 4.8 CAT KHANH
- 4.8.1 CAT KHANH Artemisinin Company Information
- 4.8.2 CAT KHANH Artemisinin Business Overview
- 4.8.3 CAT KHANH Artemisinin Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 CAT KHANH Product Portfolio
- 4.8.5 CAT KHANH Recent Developments
- 4.9 BEEPZ
- 4.9.1 BEEPZ Artemisinin Company Information
- 4.9.2 BEEPZ Artemisinin Business Overview
- 4.9.3 BEEPZ Artemisinin Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 BEEPZ Product Portfolio
- 4.9.5 BEEPZ Recent Developments
- 4.10 Novanat Bioresource
- 4.10.1 Novanat Bioresource Artemisinin Company Information
- 4.10.2 Novanat Bioresource Artemisinin Business Overview
- 4.10.3 Novanat Bioresource Artemisinin Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Novanat Bioresource Product Portfolio
- 4.10.5 Novanat Bioresource Recent Developments
5 Global Artemisinin Production by Region
- 5.1 Global Artemisinin Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Artemisinin Production by Region: 2021-2032
- 5.2.1 Global Artemisinin Production by Region: 2021-2026
- 5.2.2 Global Artemisinin Production Forecast by Region (2027-2032)
- 5.3 Global Artemisinin Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Artemisinin Production Value by Region: 2021-2032
- 5.4.1 Global Artemisinin Production Value by Region: 2021-2026
- 5.4.2 Global Artemisinin Production Value Forecast by Region (2027-2032)
- 5.5 Global Artemisinin Market Price Analysis by Region (2021-2026)
- 5.6 Global Artemisinin Production and Value, YOY Growth
- 5.6.1 North America Artemisinin Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Artemisinin Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Artemisinin Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Artemisinin Production Value Estimates and Forecasts (2021-2032)
6 Global Artemisinin Consumption by Region
- 6.1 Global Artemisinin Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Artemisinin Consumption by Region (2021-2032)
- 6.2.1 Global Artemisinin Consumption by Region: 2021-2026
- 6.2.2 Global Artemisinin Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Artemisinin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Artemisinin Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Artemisinin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Artemisinin Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Artemisinin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Artemisinin Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Artemisinin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Artemisinin Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Artemisinin Production by Type (2021-2032)
- 7.1.1 Global Artemisinin Production by Type (2021-2032) & (MT)
- 7.1.2 Global Artemisinin Production Market Share by Type (2021-2032)
- 7.2 Global Artemisinin Production Value by Type (2021-2032)
- 7.2.1 Global Artemisinin Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Artemisinin Production Value Market Share by Type (2021-2032)
- 7.3 Global Artemisinin Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Artemisinin Production by Application (2021-2032)
- 8.1.1 Global Artemisinin Production by Application (2021-2032) & (MT)
- 8.1.2 Global Artemisinin Production Market Share by Application (2021-2032)
- 8.2 Global Artemisinin Production Value by Application (2021-2032)
- 8.2.1 Global Artemisinin Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Artemisinin Production Value Market Share by Application (2021-2032)
- 8.3 Global Artemisinin Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Artemisinin Value Chain Analysis
- 9.1.1 Artemisinin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Artemisinin Production Mode & Process
- 9.2 Artemisinin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Artemisinin Distributors
- 9.2.3 Artemisinin Customers
10 Global Artemisinin Analyzing Market Dynamics
- 10.1 Artemisinin Industry Trends
- 10.2 Artemisinin Industry Drivers
- 10.3 Artemisinin Industry Opportunities and Challenges
- 10.4 Artemisinin Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst